MedaPhor Group plc provided earnings guidance for the year ending December 31, 2015. For the period, the company expects sales to be in the range of £2.1 million to £2.5 million, yielding an adjusted loss (before share based payment charge) in the range of £1.7 million to £2.0 million. Year-end cash is expected to be at around £1.2 million.